DRTS Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: March 27, 2026
Report Source: 2025 Annual Report
Alpha Tau Medical Ltd. Stock Analysis DRTS
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The firm has one subsidiary Healthcare Capital Corp.
Read More Alpha Tau Medical Ltd (DRTS) Chart
Key Statistics of Alpha Tau Medical Ltd (DRTS)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$10.26Volume
901.30KP/E Ratio (TTM)
-52 Week Range
Market Cap
650.39MAvg. Volume
750.06KDividend Yield
-Financial Metrics & Statements of Alpha Tau Medical Ltd (DRTS)
FAQ's for Alpha Tau Medical Ltd (DRTS)
- According to Musaffa’s Shariah screening methodology, Alpha Tau Medical Ltd (DRTS) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.